Immunophenotype of EATL
| . | EATL type 1 . | EATL type 2 . | P . |
|---|---|---|---|
| CD3e | 89% | 95% | NS |
| CD2 | 43% | 53% | NS |
| CD5 | 17% | 6% | NS |
| CD4 | 11% | 5%* | NS |
| CD8 | 43% | 63% | NS |
| CD30 | 37.5% | 12.5%* | .09 |
| CD56 | 30% | 73% | .01 |
| TIA-1 | 81% | 87.5% | NS |
| EBV (EBER-ISH) | 10%* | 12%* | NS |
| . | EATL type 1 . | EATL type 2 . | P . |
|---|---|---|---|
| CD3e | 89% | 95% | NS |
| CD2 | 43% | 53% | NS |
| CD5 | 17% | 6% | NS |
| CD4 | 11% | 5%* | NS |
| CD8 | 43% | 63% | NS |
| CD30 | 37.5% | 12.5%* | .09 |
| CD56 | 30% | 73% | .01 |
| TIA-1 | 81% | 87.5% | NS |
| EBV (EBER-ISH) | 10%* | 12%* | NS |
NS indicates not significant.
Only a subpopulation of likely reactive cells were positive.